Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Individualizing Pharmacotherapy: A Novel Optimization Strategy to Increase Smoking Cessation in the African American Community

NCT03897439 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.

NCT NCT03897439
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03897439 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Individualizing Pharmacotherapy: A Novel Optimization Strategy to Increase Smoking Cessation in the African American Community
Lead sponsor
University of Kansas Medical Center
Phase
Phase 3
Overall status
Completed
Start date
May 1, 2019
Completion date
January 30, 2022
Enrollment
392 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

smoking cessation